ONCOSEC MED INC's ticker is ONCSXXXX and the CUSIP is 68234L207. A total of 34 filers reported holding ONCOSEC MED INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $30,000 | -53.1% | 53,513 | -46.7% | 0.00% | – |
| Q4 2018 | $64,000 | +166.7% | 100,325 | +484.1% | 0.00% | – |
| Q3 2018 | $24,000 | 0.0% | 17,175 | 0.0% | 0.00% | – |
| Q2 2018 | $24,000 | -25.0% | 17,175 | 0.0% | 0.00% | – |
| Q1 2018 | $32,000 | +77.8% | 17,175 | +58.8% | 0.00% | – |
| Q4 2017 | $18,000 | +80.0% | 10,816 | +4.7% | 0.00% | – |
| Q3 2017 | $10,000 | -28.6% | 10,331 | -11.8% | 0.00% | – |
| Q2 2017 | $14,000 | -6.7% | 11,717 | +3.2% | 0.00% | – |
| Q1 2017 | $15,000 | 0.0% | 11,356 | -1.2% | 0.00% | – |
| Q4 2016 | $15,000 | -21.1% | 11,497 | +5.6% | 0.00% | – |
| Q3 2016 | $19,000 | -24.0% | 10,889 | -28.9% | 0.00% | – |
| Q2 2016 | $25,000 | -24.2% | 15,315 | +18.6% | 0.00% | – |
| Q1 2016 | $33,000 | -2.9% | 12,917 | -7.9% | 0.00% | – |
| Q4 2015 | $34,000 | -49.3% | 14,029 | +8.6% | 0.00% | – |
| Q3 2015 | $67,000 | – | 12,917 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 2,064,297 | $3,881,000 | 0.64% |
| Avoro Capital Advisors LLC | 4,007,696 | $7,534,000 | 0.36% |
| Crestline Management, LP | 201,860 | $379,000 | 0.05% |
| Point72 Asset Management, L.P. | 3,215,000 | $6,044,000 | 0.02% |
| Sofinnova Investments, Inc. | 66,965 | $126,000 | 0.02% |
| FNY Managed Accounts LLC | 10,000 | $18,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 269,432 | $507,000,000 | 0.01% |
| DRW Securities, LLC | 70,000 | $132,000 | 0.01% |
| Perceptive Advisors | 50,000 | $94,000 | 0.00% |
| Cable Hill Partners, LLC | 4,000 | $8,000 | 0.00% |